CLS 007Alternative Names: CLS007
Latest Information Update: 10 Dec 2016
At a glance
- Originator Cutanea Life Sciences
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Acne
Most Recent Events
- 08 Dec 2016 Preregistration for Acne in USA (Topical)